APA (7th ed.) Citation

Signoriello, E., Lus, G., Saccà, F., Puthenparampil, M., Coppola, C., Di Pietro, A., . . . Signori, A. (2023). Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence. Journal of Clinical Medicine, 12(5), 1768. https://doi.org/10.3390/jcm12051768

Chicago Style (17th ed.) Citation

Signoriello, Elisabetta, et al. "Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence." Journal of Clinical Medicine 12, no. 5 (2023): 1768. https://doi.org/10.3390/jcm12051768.

MLA (9th ed.) Citation

Signoriello, Elisabetta, et al. "Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence." Journal of Clinical Medicine, vol. 12, no. 5, 2023, p. 1768, https://doi.org/10.3390/jcm12051768.